Effects of Ca channel agonists on 45Ca uptake differ depending on the state of NG108-15 cells

Jpn J Pharmacol. 1994 Mar;64(3):209-12. doi: 10.1254/jjp.64.209.

Abstract

We investigated the effects of various Ca channel agonists (Ca agonist) derived from 1,4-dihydropyridine on KCl-stimulated 45Ca uptake by differentiated and undifferentiated neuroblastoma x glioma hybrid NG108-15 cells with and without dibutyryl cAMP. Ca agonists Bay K 8644, YC-170 and CGP 28392 enhanced KCl-stimulated 45Ca uptake in differentiated NG108-15 cells, but only slightly in undifferentiated NG108-15 cells. The rank order of the enhancing effects was roughly Bay K 8644 > YC-170 > > CGP 28392. These results suggest that there is some difference between the mechanism by which these Ca agonists affect KCl-stimulated 45Ca uptake in differentiated and undifferentiated NG108-15 cells, although the nature of that difference is not clear.

MeSH terms

  • Bucladesine / pharmacology
  • Calcium / pharmacokinetics*
  • Calcium Channel Agonists / pharmacokinetics*
  • Calcium Radioisotopes
  • Cell Differentiation
  • Glioma
  • Humans
  • Hybrid Cells / drug effects*
  • Hybrid Cells / metabolism*
  • Neuroblastoma
  • Potassium Chloride / pharmacology
  • Stimulation, Chemical
  • Tumor Cells, Cultured

Substances

  • Calcium Channel Agonists
  • Calcium Radioisotopes
  • Bucladesine
  • Potassium Chloride
  • Calcium